m+Medelevator.RU
← Поиск публикаций
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025

Combination of rhinoshave and fractional ablative CO2 laser therapy for fine contouring of pronounced rhinophyma - A monocentric retrospective study with long-term follow-up.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Hempel Conrad, Seitz Anna-Theresa, Schnabel Viktor, Mittank-Weidner Till, Simon Jan-Christoph, Grunewald Sonja

Аннотация

BACKGROUND: Currently, there are no effective drug therapy options that lead to the regression of rhinophyma. Many surgical procedures for treating rhinophyma have been published; however, there are limited data on their effectiveness. In addition, these treatment options often lead to persistent hypopigmented scarring if excessive ablation or heat is applied.

PATIENTS AND METHODS: To prevent excessively deep ablation and enable precise nasal contouring, a combination therapy was developed, integrating classic rhinoshave for coarse ablation followed by laser fine contouring. Fractional ablation was performed to minimize heat accumulation. Here, we report on 45 patients with pronounced rhinophyma who underwent this treatment at the Dermatology Clinic of Leipzig University between 2016 and 2024. The median follow-up period was 51 months (range: 6-96 months).

RESULTS: The majority of the patients were either very satisfied or satisfied with the postoperative outcome (n = 26; 92.3%). One case of postoperative hemorrhage was reported (2.2%). There was no wound infection observed, and the recurrence rate was 17.9%.

CONCLUSIONS: The combination of rhinoshave and fractional ablative CO2 laser treatment is a feasible and safe therapeutic procedure and ensures high patient satisfaction with a low recurrence rate.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты